Summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Full Text
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 124 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 124
To amend title XIX of the Social Security Act to provide incentives for
education on the risk of renal medullary carcinoma in individuals who
are receiving medical assistance under such title and who have sickle
cell disease.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 3, 2025
Mr. Green of Texas introduced the following bill; which was referred to
the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend title XIX of the Social Security Act to provide incentives for
education on the risk of renal medullary carcinoma in individuals who
are receiving medical assistance under such title and who have sickle
cell disease.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Byron Nash Renal Medullary Carcinoma
Awareness Act of 2023''.
SEC. 2. PROVIDING INCENTIVES FOR EDUCATION ON RISK OF RENAL MEDULLARY
CARCINOMA TO INDIVIDUALS WITH SICKLE CELL DISEASE UNDER
MEDICAID.
(a) In General.--
Section 1903(a)(3)(E)(ii) of the Social Security
Act (42 U.S.C. 1396b(a)(3)(E)(ii)) is amended by inserting ``, renal
medullary carcinoma,'' after ``stroke'' each place it appears.
(b) Effective Date.--The amendments made by subsection (a) shall
apply with respect to items and services furnished on or after the date
of the enactment of this Act.
<all>